Lo Andrew - Insider Non-Derivative Transactions at BridgeBio Pharma, Inc. (BBIO) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Nov 18, 2025, Lo Andrew's relationship to BridgeBio Pharma, Inc. (BBIO) is Director, and currently has 81,576 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other BBIO insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Lo Andrew - Insider Non-Derivative Transactions of BBIO Common Stock

Lo Andrew - Insider Non-Derivative Transactions at BBIO

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Nov 19, 2025	Sell -- (Common Stock)	30993	66.05	50583
Nov 19, 2025	Sell -- (Common Stock)	24007	65.23	81576
Nov 18, 2025	Sell -- (Common Stock)	3798	67.06	14089
Nov 18, 2025	Sell -- (Common Stock)	36801	66.63	17887
Jun 21, 2025	Acquisition -- (Common Stock)	6589	0	54688
May 3, 2025	Sell -- (Common Stock)	100000	38.5	105583